AU2001291604A1 - Use of proton pump inhibitors for treating diseases of the locomotor system - Google Patents

Use of proton pump inhibitors for treating diseases of the locomotor system

Info

Publication number
AU2001291604A1
AU2001291604A1 AU2001291604A AU9160401A AU2001291604A1 AU 2001291604 A1 AU2001291604 A1 AU 2001291604A1 AU 2001291604 A AU2001291604 A AU 2001291604A AU 9160401 A AU9160401 A AU 9160401A AU 2001291604 A1 AU2001291604 A1 AU 2001291604A1
Authority
AU
Australia
Prior art keywords
treating diseases
proton pump
pump inhibitors
locomotor system
locomotor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291604A
Inventor
Wilhelm Aicher
Steffen Gay
Michael George
Otto Muller
Thomas Pap
Wolfgang Parak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaetsklinikum Tuebingen
Original Assignee
Eberhard Karls Universitaet Tuebingen
Universitaetsklinikum Tuebingen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eberhard Karls Universitaet Tuebingen, Universitaetsklinikum Tuebingen filed Critical Eberhard Karls Universitaet Tuebingen
Publication of AU2001291604A1 publication Critical patent/AU2001291604A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001291604A 2000-08-11 2001-08-09 Use of proton pump inhibitors for treating diseases of the locomotor system Abandoned AU2001291604A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10040052.3 2000-08-11
DE10040052A DE10040052A1 (en) 2000-08-11 2000-08-11 Use of proton pump inhibitors for the treatment of inflammation, in particular diseases of the musculoskeletal system
PCT/DE2001/003179 WO2002013796A2 (en) 2000-08-11 2001-08-09 Use of proton pump inhibitors for treating diseases of the locomotor system

Publications (1)

Publication Number Publication Date
AU2001291604A1 true AU2001291604A1 (en) 2002-02-25

Family

ID=7652636

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291604A Abandoned AU2001291604A1 (en) 2000-08-11 2001-08-09 Use of proton pump inhibitors for treating diseases of the locomotor system

Country Status (3)

Country Link
AU (1) AU2001291604A1 (en)
DE (2) DE10040052A1 (en)
WO (1) WO2002013796A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070027189A1 (en) * 2003-09-18 2007-02-01 Altana Pharma Ag Use of known active ingredients as radical scavengers
GB0403165D0 (en) * 2004-02-12 2004-03-17 Ct Novel uses for proton pump inhibitors
EP1779848A1 (en) * 2005-10-28 2007-05-02 Nikem Research S.R.L. V-ATPase inhibitors for the treatment of inflammatory and autoimmune diseases
JP5855849B2 (en) 2010-06-04 2016-02-09 花王株式会社 Novel hyaluronic acid degradation promoting factor and inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989003830A1 (en) * 1987-10-30 1989-05-05 Aktiebolaget Hässle 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss
JPH01203325A (en) * 1988-02-08 1989-08-16 Takeda Chem Ind Ltd Osteoporosis preventing remedy
SE8903529D0 (en) * 1989-10-24 1989-10-24 M Hersloef MEDICAL USE
SG49853A1 (en) * 1993-08-16 2001-07-24 Novartis Ag Novel macrolides and the use thereof
US5763480A (en) * 1994-02-14 1998-06-09 The Jewish Hospital Of St. Louis Inhibitors of cell-medicated disorders
US6010852A (en) * 1997-02-27 2000-01-04 Incyte Pharmaceuticals, Inc. Human proton atpase subunit
DE19828068C2 (en) * 1998-06-24 2003-12-18 Peter Dietsch Specific inhibitor of osteoclast bone resorption
AUPQ051099A0 (en) * 1999-05-24 1999-06-17 Tachas, George Dr Novel products and processes in treatment and/or prophylaxis

Also Published As

Publication number Publication date
WO2002013796A3 (en) 2002-09-12
DE10193322D2 (en) 2003-08-21
DE10040052A1 (en) 2002-03-07
WO2002013796A2 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2001294515A1 (en) Use of stat-6 inhibitors as therapeutic agents
AU2001288271A1 (en) Methods for treating inflammatory diseases
AU2002359498A1 (en) Treated water dispensing system
AU2002239491A1 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
AU2002210462A1 (en) Transdermal therapeutic system for treating restless-legs-syndrome
AU2002210463A1 (en) Transdermal therapeutic system
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2001266838A1 (en) Inhibitors of matriptase for the treatment of cancer
AU2000258352A1 (en) Acupuncture points stimulation for treating various diseases
AU2001228703A1 (en) Use of cox-2 inhibitors for the treatment of constipation
AU2001232787A1 (en) Airway alkalinization as therapy for airway diseases
HUP0204448A3 (en) Trnasdermal therapeutic system for the delivery of lerisetron
AU2001282684A1 (en) Means for electrochemical treatment of water
AU2001289936A1 (en) Use of amino acids for treating pain
AU2001291604A1 (en) Use of proton pump inhibitors for treating diseases of the locomotor system
IL155769A0 (en) Method for the treatment of inflammation
AU2001285156A1 (en) Combination therapy for the treatment of migraine
AU2001232053A1 (en) System for the extracorporeal treatment of blood
AU2001269439A1 (en) Medicinal preparations for treating sex hormone-dependent diseases
AU2001292818A1 (en) Use of transcription factors for treating inflammation and other diseases
AU2001294033A1 (en) Methods for treating disorders of the female reproductive system
WO2003043614A3 (en) Reversible proton pump inhibitors for the treatment of airway disorders